Cardiometabolic features of polycystic ovary syndrome.
Polycystic ovary syndrome (PCOS) is a complex disorder comprising both hormonal and metabolic abnormalities that include impaired glucose tolerance, type 2 diabetes, vascular disease, dyslipidemia, and obstructive sleep apnea. Insulin resistance is a central pathogenetic factor in PCOS that seems to result from a post-receptor-binding defect in insulin action. Insulin resistance and the consequent development of hyperinsulinemia contribute to the constellation of cardiometabolic abnormalities noted above. Although there is a paucity of data in regard to cardiovascular event rates and mortality in PCOS, an increased prevalence of cardiovascular risk factors has been well documented. Attention to the metabolic risks associated with PCOS, starting as early as adolescence, is essential to the medical care of these patients.
Hoffman
Leslie K
LK
Section of Endocrinology, Diabetes and Metabolism, The University of Chicago, 5841 S Maryland Avenue, Mail Code 1027, Chicago, IL 60637, USA.
Ehrmann
David A
DA
D002318:Cardiovascular Diseases / Q000150:complications / Q000378:metabolism*; D005260:Female; D018149:Glucose Intolerance / Q000150:complications / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000378:metabolism
D007004:Hypoglycemic Agents